The validity and reliability of a screening questionnaire for Parkinson's disease in a community

Journal of Preventive Medicine and Public Health

Volumn 43, Issue 1, 2010, Pages 9-17

  Kim, Jong Hun ^a   Cheong, Hae Kwan ^a   Lee, Chong Sik ^b   Yi, Sung Eun ^c   Park, Kun Woo ^d  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Kwandong University College of Medicine   (South Korea)

^d Korea University College of Medicine   (South Korea)

Author keywords

Community; Parkinson's disease; Questionnaire; Reliability; Screening; Validity

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTENT VALIDITY; CONTROLLED STUDY; CRONBACH ALPHA COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEALTH SURVEY; HUMAN; INTERNAL CONSISTENCY; KAPPA STATISTICS; MALE; MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; QUESTIONNAIRE; REPEAT PROCEDURE; SCREENING TEST; TEST RETEST RELIABILITY;

AGED; AGED, 80 AND OVER; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 77953677948     PISSN: 19758375     EISSN: None     Source Type: Journal    
DOI: 10.3961/jpmph.2010.43.1.9     Document Type: Article

References (24)

1. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 1999; 52(6): 1214-1220.
2. Taylor CA, Saint-Hilaire MH, Cupples LA, Thomas CA, Burchard AE, Feldman RG, et al. Environmental, medical, and family history risk factors for Parkinson's disease: A New England-based case control study. Am J Med Genet 1999; 88(6): 742-749.
3. Morgante L, Rocca WA, Di Rosa AE, De Domenico P, Grigoletto F, Meneghini F, et al. Prevalence of Parkinson's disease and other types of parkinsonism: A door-to-door survey in three Sicilian municipalities. The Sicilian Neuro-Epidemiologic Study (SNES) Group. Neurology 1992; 42(10): 1901-1907.
4. Wang SJ, Fuh JL, Liu CY, Lin KP, Chang R, Yih JS, et al. Parkinson's disease in Kin-Hu, Kinmen: A community survey by neurologists. Neuroepidemiology 1994; 13(1-2): 69-74.
5. MacDonald BK, Cockerell OC, Sander JW, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000; 123(Pt 4): 665-676.
6. Newman EJ, Grosset KA, Grosset DG. Geographical difference in Parkinson's disease prevalence within West Scotland. Mov Disord 2009; 24(3): 401-406.
7. von Campenhausen S, Bornschein B, Wick R, Bötzel K, Sampaio C, Poewe W, et al. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol 2005; 15(4): 473-490.
8. Seo WK, Koh SB, Kim BJ, Yu SW, Park MH, Park KW, et al. Prevalence of Parkinson's disease in Korea. J Clin Neurosci 2007; 14(12): 1155-1157.
9. Rare Disease Center, Korea Centers for Disease Prevention and Control. Genetic and rare disease statistics. [cited 2009 Sep 1]; Available from: URL:http://helpline.cdc.go.kr/web/download/download-view.html?idx=252&bname= cyber&cate-idx=0000000003. (Korean)
10. Park J, Yoo CI, Sim CS, Kim JW, Yi Y, Shin YC, et al. A retrospective cohort study of Parkinson's disease in Korean shipbuilders. Neurotoxicology 2006; 27(3): 445-449.
11. Tanner CM, Gilley DW, Goetz CG. A brief screening questionnaire for parkinsonism. Ann Neurol 1990; 28: 267-268.
12. Duarte J, Claveria LE, de Pedro-Cuesta J, Sempere AP, Coria F, Calne DB. Screening Parkinson's disease: A validated questionnaire of high specificity and sensitivity. Mov Disord 1995; 10(5): 643-649.
13. Mutch WJ, Smith WC, Scott RF. A screening and alerting questionnaire for parkinsonism. Neuroepidemiology 1991; 10(3): 150-156.
14. Jhoo JH, Kim KW, Lee DY, Youn JC, Lee TJ, Choo IH, et al. Comparison of the performance in two different Korean versions of mini-mental state examination: MMSE-KC and K-MMSE. J Korean Neuropsychiatr Assoc 2005; 44(1): 98-104. (Korean)
15. Yang DW, Cho B, Chey JY, Kim SY, Kim BS. The development and validation of Korean Dementia Screening Questionnaire (KDSQ). J Korean Neurol Assoc 2002; 20(2): 135-141. (Korean)
16. Taylor KS, Counsell CE, Harris CE, Gordon JC. Screening for undiagnosed parkinsonism in people aged 65 years and over in the community. Parkinsonism Related Disord 2006; 12(2): 79-85.
17. Viera AJ, Garrett JM. Understanding interobserver agreement: The kappa statistic. Fam Med 2005; 37(5): 360-363.
18. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33(1): 159-174.
19. Yip CW, Tan EK. Test-retest repeatability of assessing environmental and lifestyle factors in Parkinson's disease. Mov Disord 2008; 23(7): 1032-1036.
20. Sarangmath N, Rattihalli R, Ragothaman M, Gopalkrishna G, Doddaballapur S, Louis ED, et al. Validity of a modified Parkinson's disease screening questionnaire in India: Effects of literacy of participants and medical training of screeners and implications for screening efforts in developing countries. Mov Disord 2005; 20(12): 1550-1556.
21. Chan DK, Hung WT, Wong A, Hu E, Beran RG. Validating a screening questionnaire for parkinsonism in Australia. J Neurol Neurosurg Psychiatry 2000; 69(1): 117-120.
22. Racette BA, Tabbal SD, Jennings D, Good LM, Perlmutter JS, Evanoff BA. A rapid method for mass screening for parkinsonism. Neurotoxicology 2006; 27(3): 357-361.
23. Nicoletti A, Salemi G, Morgante L, Le Pira F, Epifanio A, Reggio A, et al. A screening instrument for a Sicilian neuroepidemiological survey in the elderly. Arch Gerontol Geriatr 2004; 38(1): 37-44.
24. Racette BA, Rundle M, Parsian A, Perlmutter JS. Evaluation of a screening questionnaire for genetic studies of Parkinson's disease. Am J Med Genet 1999; 88(5): 539-543.